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Abstract
Greater understanding of the mechanisms (mediators) by which behavioral change interventions
work is critical to developing theory and refining interventions. Although systematic reviews have
been advocated as a method for exploring mediators, this is rarely done. One challenge is that
intervention researchers typically test only two paths of the mediational model: the effect of the
intervention on mediators and on outcomes. We addressed this challenge by drawing information
not only from intervention studies but also from observational studies, which provide data on
associations between potential mediators and outcomes. We also reviewed qualitative studies of
participants’ perceptions of why and how interventions worked. Using data from intervention (n=
37) and quantitative observational studies (n=55), we conducted a meta-analysis of the mediation
effects of eight variables. Qualitative findings (n=6) contributed to more in-depth explanations for
findings. The methods used have potential to contribute to understanding of core mechanisms of
behavioral change interventions.
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Systematic reviews of complex, behavioral change interventions are key to summarizing
evidence on their effectiveness. Effectiveness reviews provide little guidance, however, on
the mechanisms or mediators by which interventions effect change and achieve desired
outcomes, information that is central to the theory underlying the intervention (Green &
Glasgow, 2006; Hawe, Shiell, & Riley, 2004). Synthesizing evidence on the mechanisms by
which behavioral change interventions work could contribute to building theory and further
refining interventions. To address this need, we developed a mixed-methods approach to
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systematically reviewing the literature to synthesize findings on the mechanisms that are
responsible for the effects of behavioral change interventions. We used as our test case
interventions to improve adherence to antiretroviral therapy (ART) in adults with HIV/
AIDS.
CHALLENGES IN IDENTIFYING AN INTERVENTION’S CORE MECHANISMS
Researchers who have systematically reviewed the findings of studies testing ART
adherence have found considerable variation in the effects of interventions across studies
(e.g., Amico, Harman, & Johnson, 2006), and yet their reviews provide only limited
evidence to explain this variation. One approach reviewers have taken to identify the factors
make some interventions more effective than others has been to assess the effects of the
different strategies used, such as provision of didactic information, interactive discussions,
and external reminders (Rueda et al., 2006; Simoni, Pearson, Pantalone, Marks, & Crepaz,
2006). However, the actual strategies delivered to participants in a study are not always
clear. Behavioral change interventions are often complex, with multiple and flexible
strategies (Rychetnik, Frommer, Hawe, & Shiell, 2002; van Dulmen et al., 2007). They may
be tailored to the preferences and needs of subgroups, or individualized to the needs of each
person. As a result, interveners deliver different components or deliver components
differently across participants. Alternatively, many researchers take a “shot gun” approach,
designing interventions with multiple strategies with the goal of hitting at least some of
participants’ needs (Sandelowski, Voils, Chang, & Lee, 2009).
Recently, scholars have advocated identifying an intervention’s “core mechanisms” or “core
elements” as an approach to identifying those components of an intervention that are
responsible for its effects (Hawe, Shiell, & Riley, 2004; McKleroy et al., 2006). Core
elements are those mechanisms that are central to the theory underlying the intervention, the
processes or mediators by which the intervention effected change and achieved the desired
outcomes (McKleroy et al., 2006). In previous reviews of ART adherence interventions,
authors have broadly categorized interventions according to their overall theoretical
approach, most commonly as cognitive, behavioral, and/or affective (e.g., Cote & Godin,
2005; Simoni et al., 2006). Each of these approaches posits that interventions improve
adherence through their effects on a range of different mediators such as coping, knowledge,
belief, and self-efficacy (cognitive interventions), barriers and facilitators to behavior
change (behavioral interventions), and emotional wellbeing and social support (affective
interventions; Munro, Lewin, Swart, & Volmink, 2007; van Dulmen et al., 2007). Although
reviewers of ART adherence interventions have grouped interventions according to
theoretical constructs, they have not focused their reviews on the evidence in support of the
mediators associated with those constructs. As a result, we have only a limited
understanding of the mechanisms by which different interventions affect adherence,
knowledge that is central to building theory and developing more effective interventions.
Systematic reviews have long been advocated as a method for exploring mediators (Shadish,
1996), but few have done so (Finney, 2009). There are three major challenges to
synthesizing evidence on mediation. Synthesis of findings on mediation ideally would
involve meta-analysis of the results of within-study analyses of mediation. Yet, because
researchers infrequently include mediation analysis in their study designs, within-study
analyses are not available. A second challenge is that intervention researchers only rarely
report the full range of data necessary to calculate mediation. The mediational model is often
depicted as a triangle with relationships among interventions, mediators, and outcomes
(Figure 1). Establishing mediation involves assessing associations across all three sides of
the triangle: the intervention’s effect on the mediator (path a), the mediator’s effect on the
outcome (path b), and the intervention’s effect on the outcome (path c; MacKinnon,
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Fairchild, & Fritz, 2007). However, intervention researchers typically test only two paths of
the mediational model: the effect of the intervention on the mediator (path a) and on the
outcome (path c). Therefore, there is insufficient information to completely analyze a
mediational model. A third challenge is the inconsistency across studies in the way
researchers conceptualized and measured potential mediators. To address these challenges,
we drew findings not only from intervention studies but also from observational studies,
which provide data on associations between potential mediators and outcomes (path b). We
also reviewed qualitative studies of participants’ and interveners’ perceptions of why and
how interventions worked to further illuminate the ways that mediators functioned to affect
outcomes (Miller, Druss, & Rohrbaugh, 2003).
PURPOSE
Our purpose in this paper is to describe a mixed-methods approach to synthesize findings on
core mechanisms, using as our test case interventions to improve adherence to ART in adults
with HIV/AIDS. We developed this approach in the course of a larger study the purpose of
which was to develop methods for synthesizing qualitative and quantitative research. The
method is novel because it integrates findings from intervention, quantitative observational,
and qualitative studies. We integrated findings from across studies to identify potential
mediators of ART adherence, synthesize evidence on potential mediators’ relationships to
interventions and adherence, and summarize findings on participants’ perceptions of why
and how interventions worked.
METHODS
We used a mixed-methods approach to integrate findings from reports of intervention,
quantitative observational, and qualitative studies with the aim of synthesizing the evidence
in support of potential mediators of the effects of interventions on adherence. For
quantitative findings, we used meta-analysis techniques to synthesize findings specific to
each relationship in the mediational model (Figure 1) and to test mediation effects. We
identified themes in qualitative findings that related to participant and intervener perceptions
of the mechanisms by which interventions affected adherence and used these findings to add
further depth to the findings from the meta analysis.
Literature search
We searched for publications reporting the findings from three types of studies of ART
adherence among adults in the US, including reports of: (a) intervention studies of the
effects of an intervention on adherence and/or on potential mediators of adherence; (b)
quantitative observational studies (i.e., cross sectional surveys) addressing correlations
between potential mediators and adherence; and (c) qualitative studies of participants’
perceptions of an intervention they received. We searched Academic Search Premier,
CINHAL, PubMed, PsychINFO, and Sociological Abstracts for the time period 2002 to
August 2009 using search terms related to HIV, antiretroviral treatment, and adherence. We
included only studies conducted in the US with adult participants with none of the following
characteristics that may alter the adherence experience (incarceration, serious mental illness,
pregnancy). Because we are interested in developing methods for synthesizing complex
behavioral change interventions, we included intervention studies that tested interventions
involving repeated interactions between interveners and participants. All included
intervention studies tested either teaching/counseling or directly observed therapy
interventions; we excluded studies that simply tested the effects of a device (e.g., electronic
reminder), journaling, or medications (e.g., antidepressant) and involved minimal interaction
between intervener and participant. (Further detail on search terms and inclusion criteria are
available on request to the corresponding author). Because of the volume of reports of
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quantitative observational studies and because of our primary study focus on developing
methods (as opposed to reporting the results of a comprehensive review of literature), we
limited our search for this type of study to more recent publications and began that search at
2005.
We identified 37 relevant reports of ART intervention studies, 55 reports of quantitative
observational studies, and 4 reports of qualitative studies that addressed participants’
perceptions of ART adherence interventions. Qualitative data on participants’ perceptions
also were included from two intervention studies in which researchers asked participants or
interveners open-ended questions about the intervention, bringing the number of studies
with qualitative findings to six. Tables 1–3 present descriptive statistics for studies included
in the review.
Data extraction
Data extraction was conducted by two members of the research team with differences in
coding resolved by consensus. (The data extraction tool is available from the first author on
request). The data extracted from the study reports included sample size, sample
demographics, potential mediators, quantitative data on the relationships between potential
mediators and adherence, intervention effects on ART adherence and on potential mediators
of adherence, qualitative data on participants’ and interveners’ perceptions of why and how
interventions improved adherence.
A potential mediator was conceptualized as any measured variable (or qualitative finding)
that plausibly could be affected by an intervention and also have an effect on adherence.
Ideally, we would have grouped studies according to their underlying theories and explored
mediators within each of those groupings. However, only a minority of intervention
researchers report data on potential mediators and even fewer identify theories. Therefore, to
make the most of the data available, we combined all interventions into a single group.
Identifying potential mediators
For each of the three types of reports, the potential mediators extracted were reviewed by
one of three investigators who independently grouped factors that were conceptually similar
to identify and define a parsimonious list of potential mediators. A fourth investigator
reviewed and integrated the three lists in consultation with the study team to create the list of
eight potential mediators shown in Table 4 with their definitions. This list includes all
mediators for which data were available in at least two reports of observation or intervention
studies. As detailed in table 1, only 13 of the intervention studies included data on potential
mediators.
Analysis of quantitative data
We used meta-analysis techniques to synthesize findings specific to each relationship in the
mediational model (Figure 1) and to test mediation effects.
Synthesizing evidence on mediation—We used meta-analysis techniques to estimate
effect sizes and test mediation effects. All calculations were performed using the
Comprehensive Meta-Analysis (CMA) version 2 software (Borenstein, Hedges, Higgins, &
Rothstein, 2005).
Calculating effect sizes—Effect sizes for the relationships between potential mediators
and adherence (path b) were computed from the observational studies. The size of the effect
of the interventions on potential mediators (path a) and on adherence (path c) were
computed from the intervention studies (see Figure 1). Both sets of studies were required, as
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none of the reports of intervention studies contain analyses of the relationship between
potential mediators and adherence (path b). When a report included more than one measure
of a construct (e.g., adherence measured by self report and pill counts), we first calculated an
effect size for each measure and then obtained the average, which was used as the effect size
for that particular construct (Durlak & Lipsey, 1991). For intervention studies with a control
group, the effect size was the standardized difference between group means (Robinson,
Berman, & Neimeyer, 1990), as this was easily calculable from the reported means and
standard deviations. For within-subject studies, where no control group was employed, the
effect size was the standardized difference between pre- and post-treatment means. If studies
measured intervention effects at multiple time points, we used the earliest post-intervention
measure to reflect the effect of the intervention. When available, we used the results from an
intent-to-treat approach over a per-protocol approach.
From the observational studies, we calculated effect sizes for bivariate and multivariable
relationships separately. Although many meta-analyses have included bivariate results only,
effect sizes derived from bivariate relationships tend to be artificially large in non-controlled
study settings (Voils, Crandell, Chang, Leeman, & Sandelowski, in press). Therefore, we
conducted analyses separately for bivariate and multivariable results and compared them,
whenever possible.
We used CMA to pool the effect size as a weighted mean, with the weight equal to the
inverse variance of each effect size. The variance of the effect size is smaller in larger
sample studies, allowing them to contribute more to the pooled effect size (Hedges & Olkin,
1985).
Analyzing mediation effects—Mediation was tested using the Sobel test (Preacher &
Hayes, 2004; Sobel, 1982), which (like many other tests of mediation) requires regression
coefficients and their standard errors. Specifically, we needed the coefficient and standard
error for the simple regression describing the effect of the intervention on the mediator (path
a), and for the multiple regression describing the effect of the mediator on adherence,
controlling for the intervention. To compute the regression coefficients and standard errors,
we first used CMA to obtain all pooled effect sizes as correlation coefficients (r). This
yielded a 3 × 3 correlation matrix for the relationship among intervention, each mediator,
and adherence.
The correlation coefficients and the sample size are sufficient information to compute the
desired standardized regression coefficients and their standard errors (Premack & Hunter;
Shadish, 1996). The correlation coefficients among all three variables were readily
available, but the sample size appropriate to compute the standard errors was not as clear. In
meta-analytic mediational modeling, it is not uncommon for the sample size in each path to
vary because it is obtained from a separate meta-analysis; the number of studies that
contribute to each meta-analysis also varies. Yet, the use of a single sample size to estimate
the standard errors of the regression coefficients for all three paths is important to retain the
validity of the Sobel test. To obtain a single sample size for the three relationships, we
followed the recommendation of Viswesvaran and Ones (1995) and used the harmonic mean
of the sample sizes across the three different relationships. A harmonic mean is always equal
to or less than an arithmetic mean and thus provides relatively conservative estimates, yet
not as conservative as using the lowest N in a pairwise deletion matrix (e.g., Albarracin et
al., 2005).
The regression estimates and standard errors are then entered into the Sobel equation, which
yields a z-score that can be compared to a normal distribution to test (using a 2-tailed test)
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for significance of the mediation effect: , where β̂a is the regression
coefficient for path a, and β̂b is the regression coefficient for path b, controlling for the
intervention. The quantities sa and sb are the corresponding standard errors.
Homogeneity analysis and regression model testing—We used random effects
meta-regression (Hunter & Schmidt, 2004) to examine potential sources of heterogeneity
across the different types of studies used in each path of the model (i.e., intervention studies
for the paths a and c, and observational studies for path b). In the 37 intervention studies,
none of the intervention characteristic covariates examined (design, setting, delivery mode,
dose, duration, and percentage of dropouts) explained a significant proportion of variance in
effect sizes across studies (Q=94.209, p<.001). Therefore, we concluded that variability in
effect sizes derived from random differences between studies and employed random effects
models for all meta-analyses.
Analysis of qualitative data—From the reports of qualitative studies, we extracted
participants’ descriptions of what they valued most about the ART adherence intervention
and participants’ and interveners’ perceptions of why and how the intervention improved
adherence. Two reviewers independently extracted key findings from each of the six reports
and then created thematic statements representing the findings across these reports
(Sandelowski & Barroso, 2007). Discrepancies were resolved by consensus. The identified
themes were then compared and contrasted to findings from the meta-synthesis to provide
greater depth and nuance to findings from the meta-analysis, and to identify areas of
congruence and discrepancy across the qualitative and quantitative findings.
RESULTS OF ANALYSIS
Evidence of mediation
Table 5 presents the results of estimates of mean correlations from the random effects model
for all available relationships extracted from the intervention and observational studies.
Interventions’ effects on potential mediators
Authors of 13 of the 37 reports of intervention studies examined the effect of the
intervention on intermediate factors that could potentially mediate the intervention’s effects.
Overall the interventions had small effects on the potential mediators (ranging from r = −.22
to .24), with significant effects on three of the eight potential mediators: self efficacy,
knowledge, and positive coping.
Mediators’ effects on adherence—In the bivariate analyses from the observational
studies, all potential mediators except knowledge showed significant relationships with
adherence. In the multivariable analyses, all potential mediators showed significant
relationships with adherence with the exception of positive coping and knowledge (Table 5).
Interventions’ effects on outcomes—Overall, the 37 interventions we reviewed had a
small effect (r=.18) on adherence, with individual effect size estimates ranging from .12 to .
23.
Analysis of mediation effects—Using methods recommended by MacKinnon et al.
(2002), we performed the Sobel test for the eight potential mediators to examine whether
they mediated the relationship between interventions and adherence. Table 6 presents the
results of the Sobel test for both bivariate and multivariable results. Using bivariate results,
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five of the potential mediators were significant: emotional wellbeing, drug/alcohol use, self-
efficacy, knowledge, and healthcare provider. Only drug/alcohol use and self-efficacy
remained significant in the multivariable results.
Participants’ perceptions of why interventions worked
In all six reports of studies with findings on participants’ perceptions of interventions,
participants cited social support from the intervener as an important component of the
intervention; in two studies, it was the most dominant theme (Bontempi, Burleson, & Lopez,
2004; Weiss et al., 2006). Participants particularly valued interveners’ attention and concern.
They also appreciated when interveners provided instrumental assistance such as
communicating with healthcare providers (Bontempi et al., 2004; Weiss et al., 2006) and
obtaining their medications (Garland et al., 2007). Participants noted the importance of
social support from peers and others in their social networks (Berg, Raminanai, Greer,
Harwood, & Safren, 2008; Bontempi et al., 2004; Weiss et al., 2006).
Participants valued the knowledge they gained (Adamian, Golin, Shain, & DeVellis, 2004;
Bontempi et al., 2004; Parry et al., 2005; Weiss et al., 2006) and skills learned (Adamian et
al., 2004; Berg et al., 2008; Weiss et al., 2006) through their participation in interventions.
They also observed that the intervention changed their perceptions of their lives and the
effects of HIV and ART medications on their health (Berg et al., 2008; Weiss et al., 2006),
improved their emotional wellbeing (Parry et al., 2005), and provided them with cues to
remind them to take their pills (e.g., pillboxes; Weiss et al., 2006).
DISCUSSION
The findings from the meta-analysis support the role of reducing drug/alcohol use and
increasing self efficacy as mediators of the effects of interventions on ART adherence in
HIV-positive adults. They also provide some support for a mediating role for emotional
wellbeing and knowledge. The thematic synthesis of participants’ experiences with HIV
interventions further confirmed these findings. Although participants did not refer to
intervention effects on drug/ alcohol use as something they valued, they did refer to the
value of aspects of the other potential mediators supported by the meta-analysis, namely,
intervention effects on skills learned (self-efficacy), emotional wellbeing, and knowledge.
Advantages to the proposed mixed-method approach
Because we extracted data from both intervention and quantitative observational studies, we
were able to do a full meta-analysis of mediation. Intervention studies contributed the data
needed to calculate the average size of the interventions’ effects on the targeted outcome
(adherence). They also provided data on the effects of interventions on a range of potential
mediators. The quantitative observational studies contributed data on the association
between potential mediators and the targeted outcome. We were able to synthesize this data
to do a full analysis of mediation effects for eight potential mediators.
Each of the three types of studies added distinct contributions to our understanding of
potential mediators. The observational studies included assessments of some potential
mediators that were largely absent from the intervention studies (e.g., beliefs). The
qualitative findings provided more in-depth explanations for discrepancies in findings across
study types. Findings from both qualitative and quantitative observational studies indicated a
strong relationship between social support and adherence. Yet, neither intervention studies
nor the meta-analysis supported social support’s role as a mediator. Findings from the
qualitative data suggest a possible explanation for this discrepancy. When interviewed,
participants in adherence programs were very specific about the source of social support the
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programs offered: support from the individuals delivering the interventions. Yet when
researchers measured their interventions’ effects, they typically assessed changes in global
social support.
Findings from the quantitative observational and qualitative studies identified avenues for
future research that would not have been identified in a synthesis of only intervention
studies. The findings from the observational studies indicate a strong correlation between
adherence and three variables that the interventions reviewed did not significantly affect
overall (beliefs, social support, healthcare provider). Few of the intervention studies
included measures of effects of interventions on these mediators, which may account, in
part, for the lack of significance; beliefs and healthcare provider were each measured in only
two studies. These findings suggest the potential value of including these variables as
mediators in future intervention studies. Findings from all three types of studies added
greater depth to understanding the mechanisms by which ART adherence interventions have
their effect.
Challenges to the proposed mixed-method approach
We encountered several challenges in our use of the mixed-methods approach described in
this review. Researchers reported on a diversity of potential mediators, and the review
required that we merge these variables into broad categories. Findings from the meta-
analysis may underestimate the overall effects of potential mediators due to the broad
operationalization of the variables in studies and the merging of more tightly operationalized
variables into broad categories for the purposes of the review. Social support offers a good
example. In most studies, it was operationalized broadly as general social support. Yet, in
one observational study, researchers addressed the effects of social support from family
members and social support from partners and found that support from partners was
associated with better adherence while support from other family members was associated
with worse adherence (Hamilton, Razzano, & Nicole, 2007). Because our review included
only the broad category of social support, we combined the findings from this study into a
single measure, thereby losing important differences in the effects of social support from
different sources. The need to group variables is a shortcoming of any systematic review.
Yet, given the variation in studies in common domains of research, it is a shortcoming
without which no review could be accomplished.
A central goal in assessing mediation is to contribute to theory development. This goal was
challenged by the largely atheoretical nature of the research reviewed. Only a minority of
authors identified the underlying theory guiding the variables they chose to measure. To
address this challenge, we inferred theoretical constructs and categorized mediators
accordingly. This workaround allowed us to synthesis existing data and begin to identify
potential mediators that were supported by data from multiple studies.
We also were limited by the small sample sizes for several of the mediators reviewed.
Limits resulting from small sample sizes were further exacerbated by our decision to only
review quantitative observational studies that have been published since 2005. The review’s
finding that some variables were not supported by the evidence was likely a result of these
small sample sizes. As a result, we cannot make claim about the absence of mediating
effects for the variables for which we identified no significant relationships. This limitation
is common to all reviews of the literature.
The review was further limited by the small number of studies of participant perspectives on
how and why interventions work. Asking participants and interveners open-ended questions
can tap into information not available through closed-ended measures. Through these open
queries, researchers can assess the extent to which their interventions worked as posited or
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through mechanisms they did not even anticipate. They also can begin to distinguish the
intervention’s essential from non-essential ingredients (Miller et al., 2003).
Conclusions
The mixed methods used in this review have potential to advance understanding of the
mechanisms by which complex, behavioral interventions have their effects. We developed
this approach in response to the lack of complete analyses of mediation in reports of
research testing behavioral change interventions. The combination of meta-analysis of
intervention and quantitative observational findings, and thematic synthesis of qualitative
findings, offered a way more fully to mine methodologically diverse reports for this
information.
To advance understanding of the theories underlying behavior change interventions, it is
essential that researchers build mediator analysis into their study designs. Yet, few reports of
intervention studies include such analyses. Accordingly, we developed an innovative
approach to extract and synthesize findings from a broad base of prior research that included
both qualitative and quantitative observational and intervention studies. The methods used
could be applied to a broad range of behavior change interventions. Identifying the core
mechanisms of interventions provides evidence in support of underlying intervention
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Table 1
Profile of Intervention Studies
Report N Male (%) Design Potential Mediators
Barnett, 2009 66 59 RCT
Collier, 2005 282 80 RCT
Cook, 2009 98 61 Pre-post study
Diekchaus, 2007 161 54 Cohort study
DiIorio, 2003 17 53 RCT
DiIorio, 2008 213 65 RCT
Golin, 2006 155 66 RCT Drug/alcohol use, social support, emotional wellbeing, positive coping, self
efficacy, beliefs, health care provider
Gross, 2009 243 79 RCT
Holzemer, 2006 240 65 RCT
Jones, 2007 177 0 RCT Positive coping
Johnson, 2007 204 78 RCT
Kalichman, 2005 30 57 Pre-post study Self efficacy, knowledge
Koenig, 2008 226 64 RCT
Levin, 2006 49 59 RCT
Ma, 2008 31 45 Pre-post study
Margolin, 2003 90 70 RCT
Milam, 2005 437 88 RCT
Murphy, 2002 33 88 RCT Social support, emotional wellbeing, positive coping, self efficacy, beliefs
Murphy, 2007 141 82 RCT Drug/alcohol use, social support, emotional wellbeing, self efficacy
Parsons, 2005 15 93 Pre-post study Drug/alcohol use
Parsons, 2007 143 79 RCT Drug/alcohol use
Purcell, 2007 966 61 RCT
Rathbun, 2005 33 85 RCT
Rawlings, 2003 195 65 RCT
Remien, 2005 215 54 RCT
Reynolds, 2008 109 85 RCT
Rosen, 2007 56 59 RCT
Safren, 2009 45 NA RCT Emotional wellbeing
Samet, 2005 151 81 RCT Drug/alcohol use
Simoni, 2007 136 55 RCT Social support, emotional wellbeing
Smith, 2003 43 80 RCT
Sorensen, 2007 66 53 RCT
Van Servellen, 2005 85 91 RCT Self efficacy, knowledge, health care provider
Wagner, 2006 230 80 RCT
Williams, 2006 171 52 RCT
Wohl, 2009 84 74 Pre-post study
Wyatt, 2004 147 0 RCT
*
RCT: randomized controlled trial
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Table 2
Profile of Quantitative Observational Studies
Report N Male (%) Potential Mediators
Amico 2007 72 54 Emotional wellbeing
Amico 2009 149 58 Self-efficacy
Arnstein 2007 636 65 Drug/alcohol use, emotional wellbeing, self- efficacy, beliefs
Atkinson 2008 130 74 Self-efficacy, beliefs
Barclay 2007 185 78 Drug/alcohol use, social support, self-efficacy, beliefs
Beach 2006 4594 61 Health care provider
Boarts 2006 57 82 Emotional wellbeing
Bottonari 2005 24 96 Emotional wellbeing
Braithwaite 2005 2774 94 Drug/alcohol use
Cardarelli 2008 101 76 Drug/alcohol use, social support, emotional wellbeing, beliefs
Cha 2008 215 67 Social support, emotional wellbeing, self- efficacy
Chander 2006 1957 64 Drug/alcohol use
Cruess 2007 117 63 Emotional wellbeing, positive coping
de Jong 2005 168 76 Drug/alcohol use
DiIorio 2009 236 66 Social support, emotional wellbeing, positive coping, self-efficacy, beliefs, health care
provider
French 2005 590 NS Emotional wellbeing
Friedman 2009 602 69 Drug/alcohol use
Gonzalez 2007 325 60 Beliefs
Graham 2007 87 75 Knowledge
Halkitis 2005 300 100 Drug/alcohol use, self-efficacy
Halkitis 2007 300 100 Drug/alcohol use
Hamilton, 2007 98 71 Social support
Hicks 2007 659 70 Drug/alcohol use
Hinkin 2007 150 83 Drug/alcohol use
Holmes 2007 116 81 Drug/alcohol use, social support, emotional wellbeing
Holstad 2006 120 60 Drug/alcohol use, social support, positive coping, self-efficacy, beliefs, health care provider
Horberg 2008 3359 83 Emotional wellbeing
Ingersoll 2005 120 62 Drug/alcohol use, emotional wellbeing, health care provider
Johnson Chesney 2006 2765 74 Self-efficacy, health care provider
Johnson Elliott 2006 552 17 Drug/alcohol use
Johnson Heckman 2009 244 71 Social support, emotional wellbeing
Kalichman 2008 145 69 Drug/alcohol use, social support, emotional wellbeing
Kapadia 2008 573 0 Drug/alcohol use, emotional wellbeing
Kremer 2009 79 65 Positive coping
Lazo 2007 1944 33 Drug/alcohol use, emotional wellbeing
Leserman 2008 105 61 Drug/alcohol use, emotional wellbeing
Liu Longshore 2006 148 0 Drug/alcohol use, emotional wellbeing, self efficacy
Liu Miller 2006 128 81 Drug/alcohol use, beliefs, health care provider
Lynam 2009 189 73 Self-efficacy, beliefs
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Report N Male (%) Potential Mediators
Meade 2009 268 50 Drug/alcohol use, social support, emotional wellbeing
Miguez-Burbano 2008 135 100 Emotional wellbeing, beliefs
Parsons 2007 272 78 Drug/alcohol use, beliefs
Parsons 2008 275 77 Drug/alcohol use, self-efficacy
Phillips, 2005 173 0 Emotional wellbeing
Pomeroy 2007 184 78 Social support, beliefs, knowledge, health care provider
Remien 2007 2849 74 Drug/alcohol use
Royal 2009 358 72 Drug/alcohol use, emotional wellbeing, beliefs
Shuter 2008 64 55 Drug/alcohol use, emotional wellbeing,
Simoni 2006 136 55 Social support, emotional wellbeing, positive coping, self-efficacy
van Servellen 2005 85 90 Social support, emotional wellbeing, self- efficacy, health care provider
Vranceanu 2008 156 76 Emotional wellbeing
Vyavaharkar 2007 224 0 Social support, positive coping
Waldrop-Valverde 2005 58 76 Emotional wellbeing
Webb 2009 168 54 Emotional wellbeing













Leeman et al. Page 21
Table 3
Profile of Qualitative Studies of Participant’s Perceptions of Interventions
Report N Design Male (%) Participants’ perception
Adamian, 2004 20 Descriptive 70 Social support, knowledge, learning new skills
Berg, 2008 14 Descriptive 93 Social support, health care provider
Bontempi, 2004 29 Descriptive 70 Social support, knowledge, instrumental assistance, social support from
peers
Garland, 2007 82 Interview data from
intervention study
72 Social support, instrumental assistance
Parry, 2005 46 Interview data from
intervention study
NA Social support, knowledge
Weiss, 2006 32 Descriptive 72 Social support, knowledge, instrumental assistance, social support from
peers, learning new skills, useful tools













Leeman et al. Page 22
Table 4
Potential Mediators of ART Adherence
• Drug/alcohol use: Current use, typically amount and frequency over a specified time period
• Social support: Perceived level of or satisfaction with social support either in general or specific to HIV status
• Emotional wellbeing: Depression, stress, anxiety, self-esteem, general psychological wellbeing, and others
• Positive coping: Use of problem and emotion-focused strategies to manage living with HIV and/or adhering to ART, includes use of
spiritual strategies
• Self efficacy: Confidence in ability to manage living with HIV and/or adhering to ART
• Beliefs: Perceptions of and attitudes towards HIV and ART and also includes measures of locus of control and outcome
expectancies specific to HIV and ART
• Knowledge: Factual understanding of HIV treatment, ART, and HIV progression
• Healthcare provider: Perception of or satisfaction with healthcare provider
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Table 5
Estimates of Mean Correlation from Random Effects Model
Mediating Variable k N Mean r 95% CI
Intervention to Mediator
 Drug/alcohol use 5 592 −.21 −.45 to .05
 Social support 4 465 −.03 −.16 to .10
 Emotional wellbeing 5 510 −.18 −.36 to .01
 Positive coping 3 365 .13* .02 to .23
 Self efficacy 5 444 .17*** .08 to .26
 Beliefs 2 188 .13 −.08 to .34
 Knowledge 2 115 .20* .002 to .38
 Healthcare provider 2 240 .10 −.04 to .24
Mediator to Adherence
Bivariate Results
 Drug/alcohol use 21 13970 −.16*** −.19 to −.12
 Social support 13 2124 .12*** .07 to .17
 Emotional wellbeing 25 7784 −.14*** −.17 to −.10
 Positive coping 6 912 .07** .02 to .17
 Self efficacy 9 2292 .27*** .12 to .41
 Beliefs 11 2597 .08* .00 to .17
 Knowledge 2 271 .27 −.07 to .54
 Healthcare provider 6 5447 .13*** .06 to .19
Multivariable Results
 Drug/alcohol use 14 8002 −.13*** −.18 to −.07
 Social support 4 634 .01* .001 to .02
 Emotional/Psychological 11 2739 −.03*** −.05 to −.01
 Positive coping 2 344 .05 −.06 to .17
 Self efficacy 8 3778 .15*** .09 to .20
 Beliefs 6 1254 .10** .03 to .16
 Knowledge 1 87 .09 −.01 to .19
 Healthcare provider 4 7655 .04*** −.005 to .08
Intervention to adherence
 All intervention studies 37 5770 .18*** .12 to .23
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Table 6
Sobel Test Results
Mediating Variable Assumed N
Intervention to mediator coefficient
(SE)
Mediator to adherence coefficient
(SE) Sobel test statistics
Bivariate Results
 Drug/alcohol use 1551 −.21 (.03) −.12 (.03) 4.13***
 Social support 1073 −.03 (.03) .12 (.03) −.96
 Emotional wellbeing 1326 −.18 (.03) −.12 (.03) 3.49***
 Positive coping 748 .13 (.04) .05 (.04) 1.18
 Self efficacy 1048 .17 (.03) .25 (.03) 4.51***
 Beliefs 510 .13 (.04) .06 (.04) 1.18
 Knowledge 239 .20 (.06) .24 (.07) 2.35*
 Healthcare provider 663 .10 (.04) .11 (.04) 1.95
Multivariable Results
 Drug/alcohol use 1509 −.21 (.03) −.09 (.03) 3.30 ***
 Social support 769 −.03 (.03) .02 (.04) −.38
 Emotional wellbeing 1200 −.18 (.03) .001 (.03) −.03
 Positive coping 515 .18 (.04) .03 (.04) .70
 Self efficacy 1115 .17 (.03) .12 (.03) 3.23**
 Beliefs 477 .13 (.04) .07 (.05) 1.38
 Knowledge 147 .20 (.06) .06 (.08) .67
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